Simple Sleep Score Shows Surprising Power to Flag Hidden Insomnia

For millions of people, insomnia is not a diagnosis but a quiet, grinding fact of life: lying awake at 3 a.m., dreading the alarm, dragging through the day. Clinicians and researchers have long relied on dedicated insomnia questionnaires to measure that burden, but a newer generation of tools asks a broader question: how healthy is your sleep overall? Now a large study of American adults suggests that one of those broad sleep-health questionnaires, the Ru-SATED scale, carries a surprisingly strong embedded signal of insomnia itself, and that the cutoff used to read that signal may need to shift depending on who is filling it out.

The study, published in the Journal of Clinical Sleep Medicine by a team led by Julia T. Boyle of VA Boston Healthcare System and Harvard Medical School together with colleagues at Virginia Commonwealth University, Hangzhou Normal University, and the National Sleep Foundation, set out to answer a deceptively simple question. If you give someone a multidimensional sleep-health questionnaire, can that score reliably tell you whether they are also carrying a heavy load of insomnia symptoms? The question matters because sleep health and insomnia are conceptually distinct. Sleep health is typically framed as a positive construct, a constellation of dimensions such as regularity, satisfaction, alertness, timing, efficiency, and duration. Insomnia, by contrast, is a clinical syndrome defined by dissatisfaction with sleep quantity or quality, accompanied by daytime impairment. Yet the two constructs share obvious territory, and the new findings quantify just how much.

The Ru-SATED scale, developed from sleep-medicine pioneer Daniel Buysse’s influential 2014 framework, asks respondents about six domains: Regularity of sleep and wake times, Satisfaction with sleep, Alertness during the day, Timing of sleep, sleep Efficiency, and sleep Duration. Each domain is scored, producing a total that summarizes a person’s overall sleep health. Higher scores indicate healthier sleep. The instrument has been translated and validated across cultures, including a Chinese adaptation among healthcare students, and a recent psychometric and diagnostic evaluation in community-dwelling adults had already hinted that Ru-SATED scores could discriminate clinically relevant sleep problems. What remained unclear was precisely how well the scale performed as a detector of elevated insomnia symptoms in a large, diverse adult sample, and whether that performance held steady across demographic groups.

To find out, the researchers recruited 3,284 U.S. adults ranging in age from 19 to 99, with an average age of about 43 and roughly 45 percent male participants. Everyone completed online versions of two questionnaires: the Ru-SATED, capturing multidimensional sleep health, and the Insomnia Severity Index, or ISI, a widely used and extensively validated measure of insomnia symptom severity. The team defined elevated insomnia symptom burden as an ISI total score of 10 or higher, a threshold commonly used to flag individuals whose symptoms warrant clinical attention. The ISI has been validated in primary care populations, college students, adolescents, and numerous language versions, making its 10-point cutoff a well-anchored benchmark for the analysis.

The analytical engine of the study was receiver operating characteristic analysis, a statistical technique borrowed from signal detection theory and long used in clinical medicine to judge how well a test separates people who have a condition from people who do not. An ROC curve plots sensitivity, the true-positive rate, against the false-positive rate across every possible cutoff of the screening measure. The area under the curve, or AUC, summarizes overall discriminative ability: an AUC of 0.5 means the test performs no better than a coin flip, while an AUC of 1.0 means perfect separation. By sweeping through all possible Ru-SATED scores and measuring how accurately each one classified participants against the ISI threshold, the researchers could identify the optimal cutoff, along with the sensitivity, specificity, and accuracy at that cutoff.

The results were clear at the level of the whole sample. A Ru-SATED score of 8 or below showed the strongest signal detection performance for identifying elevated insomnia symptoms. In other words, when someone’s composite sleep-health score dipped to 8 or less out of the scale’s range, the probability that they were also reporting clinically meaningful insomnia symptoms rose sharply enough that the low sleep-health score functioned as an effective flag. The authors interpret this as evidence of criterion-related validity: the Ru-SATED does not merely describe sleep habits in the abstract, it carries real information about insomnia burden as measured against an established clinical yardstick.

But the story grew more interesting when the team ran exploratory subgroup analyses. The optimal cutoff was not universal. Among young adults, the strongest detection performance emerged at a lower score of 7 or below, suggesting that younger people may need a more pronounced dip in overall sleep health before the scale reliably flags insomnia symptoms. Among female participants, the opposite pattern appeared, with a higher cutoff of 9 or below performing best. These demographic shifts echo a broader literature documenting sex and age differences in insomnia. Insomnia symptoms are known to be more prevalent among women, and large school-based studies have traced the emergence of those sex differences in adolescence, while sleep architecture and insomnia presentation change across the lifespan in ways that could alter how sleep-health domains map onto insomnia complaints.

The implications cut in two directions. For researchers running population-based sleep-health studies, the findings are reassuring: the Ru-SATED is not blind to insomnia, and a low score is a meaningful warning sign that can be used to identify participants who may need closer clinical assessment. That makes the scale attractive for large surveys, cohort studies, and digital screening platforms where administering a full insomnia battery to every respondent is impractical. At the same time, the subgroup results are a caution against one-size-fits-all cutoffs. A threshold of 8 may underperform in young adults and miss cases among women if applied without adjustment, and the authors emphasize that unique populations deserve special attention when these tools are deployed.

There is also a deeper conceptual takeaway. The fact that a sleep-health scale detects insomnia symptoms at all confirms what many sleep scientists have suspected: the boundary between positive sleep health and insomnia pathology is porous. The six Ru-SATED domains, particularly satisfaction and efficiency, overlap directly with the core complaints of insomnia disorder as defined in the DSM-5 and the International Classification of Sleep Disorders. A person who is dissatisfied with their sleep and inefficient at sustaining it will score poorly on both constructs. The study does not claim the Ru-SATED can diagnose insomnia, and the authors frame their results as evidence of signal detection rather than diagnostic performance, but the demonstration that the scale’s scores contain an insomnia-related signal strengthens the case for treating sleep health as a continuum that shades into clinical disorder.

Funded in part by the National Institute on Aging and supported by resources of VA Boston Healthcare System, the study arrives at a moment of growing interest in sleep as a modifiable pillar of public health, alongside diet and exercise. Roughly a third of adults report insomnia symptoms at some point, and untreated insomnia carries costs ranging from impaired cognition and mood disorders to cardiovascular and metabolic disease. Simple, validated instruments that can be deployed at scale, and whose scoring quirks across age and sex are now better understood, are exactly the kind of infrastructure that population sleep science needs. The Ru-SATED, this research suggests, is more than a wellness checklist. Buried inside its tidy six-domain score is a genuine signal of one of the world’s most common and most undertreated sleep disorders, and researchers now know where, and for whom, to listen for it.

Subject of Research: Signal detection performance of the Ru-SATED sleep health scale for identifying elevated insomnia symptoms in U.S. adults

Article Title: From sleep health to insomnia: signal detection performance of the Ru-SATED scale

Article References: Boyle, J. T., Nielson, S. A., Xu, J., Meng, R., Zhang, J., & Dzierzewski, J. M. (2026). From sleep health to insomnia: signal detection performance of the Ru-SATED scale. Journal of Clinical Sleep Medicine, 22(1), Article 116. https://doi.org/10.1007/s44470-026-00126-3

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00126-3

Keywords: sleep health, insomnia, Ru-SATED, Insomnia Severity Index, ROC analysis, signal detection, criterion-related validity, sleep medicine, psychometrics, screening, sex differences, aging